APIS ESR1 Mutations Kit
APIS ESR1 Mutations Kit
The APIS ESR1 Mutations Kit is an advanced qPCR assay for the sensitive and precise detection of mutations within the oestrogen receptor gene. The ESR1 Mutations Kit is a qualitative test, detecting eleven ESR1 mutations across three exons: exon 5 (E380Q), exon 7 (S463P) and exon 8 (P535H, L536R, L536Q, L536H, L536P, Y537C, Y537S, Y537N and D538G).
The kit includes mutation-specific probes to enable highly sensitive detection of the target mutations. Additionally, it utilises PCR clamp and blocker technology, which ensures specific amplification of the mutant sequence, even in the presence of a high wild-type background.
It is suitable for use in both centralised and decentralised settings, especially for those facilities that require a testing solution without the need for additional specialised equipment e.g. NGS.
Benefits of Using the APIS ESR1 Mutations Kit
Wide target coverage – the kit has been designed to cover 11 different ESR1 mutations
High specificity - includes clamp and blocking technology to ensure no wild-type detection
High sensitivity – all mutations are detected at ≤ 1% MAF (Mutant Allele Frequency)
Easy to use – our assays are designed to be user-friendly, with a simple protocol. The reagents have been optimised for precise and sensitive detection in human DNA.
Assay Mutations and analytical sensitivity in contrived samples
The APIS ESR1 Mutations Kit detects 11 ESR1 mutations. Contrived samples of 0.008–1.6% mutant allele frequency (MAF) were prepared with a total copy of 5000 per reaction. The LoD is based on the highest mutant allele frequency with 95% correct calls observed for each target in 24 replicates. The claimed LoD for the targets in % MAF is ≤ 1% for all targets (Table 1).
Table 1. 11 ESR1 mutations detected in the APIS ESR1 Mutations Kit. LoD in % MAF and copies (cp). The mutant copies at LoD and WT copies at LoD describe the copies of each DNA fragment in the contrived LoD samples.
Supporting Data for the APIS ESR1 Mutations Kit
Linearity
An 8-level dilution series of DNA fragments specific to each mutation were used to evaluate PCR efficiency and R-sq values (Table 2 and Figure 1).
Table 2. Linearity analysis of each target in the APIS ESR1 Mutations Kit.
Figure 1. Linear regression of the D538G mutation across the 8-level dilution series.
APIS ESR1 Mutations Kit Sensitivity & Selectivity
APIS ESR1 Mutations Kit performance with SensID ESR1 Reference Set 1% AF cfDNA (SID-000144)
Highly sensitive and specific detection of SensID ESR1 Mutation Reference Standards at 1% MAF
APIS ESR1 Mutations Kit Specifications
The kit has undergone testing as part of APIS' unique assay development pipeline, which includes in silico and wet laboratory testing. As a result, researchers can have confidence in the accuracy, sensitivity, specificity, and reliability of the kit. The qPCR assay’s efficiency and linearity were assessed using contrived synthetic DNA samples.
| Condition | Specification |
|---|---|
| Format | 10 Tubes: 6 PP mixes (Primer-Probes), 2 Buffer mixes, 1 Positive Control, 1 Negative Control |
| PCR method | qPCR |
| Instrument | Any qPCR instrument with compatible cycling and emission detection capabilities |
| Probe modifications | • 5’ FAM/3’ BHQ1 • 5’ HEX/3’ BHQ1 |
| Samples | Standard kit is sufficient for 24 samples (20 µL reaction), including pipetting overage |
| Concentration | 4X PP Mix, 2X Buffer mix |
APIS ESR1 Mutations Kit - Available now
The APIS ESR1 Mutations Kit is currently available as a research use only (RUO) product. Not applicable for use in diagnostic procedures.
For more information on this product please contact us and select ‘ESR1 Mutations Kit’
Ordering Information
| Product Name | Test Type | Kit Size | Catalogue Number | Price |
|---|---|---|---|---|
| APIS ESR1 Mutations Kit | RUO | 24 samples plus controls | 02201 (distributed by APIS) | Available upon request |
| APIS ESR1 Mutations Kit | RUO | 24 samples plus controls | 02202 (distributed by Biocartis) | Available upon request |
To order the APIS ESR1 Mutations Kit or to learn more about how our assay can elevate your breast cancer research capabilities, please contact us by clicking below.
Biocartis currently distributes to the following countries: - Austria, Belgium, Denmark, France, Germany, Greece, Hungary, Italy, Liechtenstein, Luxembourg, Malta, Netherlands, Norway, Poland, Portugal, Republic of Cyprus, Republic of Ireland, Slovenia, Spain, Sweden, Switzerland, United Kingdom, United States of America. APIS is the distributor for all other countries.